Printer Friendly

Articles from Worldwide Biotech (November 1, 2006)

1-4 out of 4 article(s)
Title Author Type Words
BASILEA REPORTS 92% CLINICAL CURE RATES FOR CEFTOBIPROLE. 849
TELBIVUDINE APPROVED IN SWITZERLAND FOR CHRONIC HEPATITIS B. 563
THROMBOGENICS STARTS PHASE IIA OF MICROPLASMIN FOR STROKE. 728
ZELOS/NEKTAR START PHASE 1 TRIAL OF INHALED OSTABOLIN-C. 801

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters